Infusion Consulting Services for Infectious Disease Practices

Infusion consulting can cover the connected operational and financial work behind an ID infusion or OPAT program. Areas may include referral workflows, documentation, coding, eligibility, prior authorization, drug acquisition, administration billing, claims, denials, payment reconciliation, accounts receivable, and payer or hospital coverage agreements. The goal is to clarify where revenue is delayed, lost, or left uncollected.

Infectious disease practices may manage cognitive services alongside infusion and OPAT activity. Each service can involve different documentation, coding, authorization, drug, administration, benefit, and payer considerations. A workflow that supports office visits may not adequately support buy-and-bill drugs or infusion claims. Reviewing the full path from referral to final payment helps reveal gaps between the work performed and the revenue collected.

Revenue leakage can originate before a claim is submitted or after payment is received. Common review areas include under-leveled visits, missed drug or administration charges, incomplete documentation, authorization problems, coding issues, contract terms, short-pays, and aging claims. Reporting by payer, service line, and provider can help trace the problem to its source and distinguish workflow issues from payment or contract concerns.

Eligibility and authorization support can include verifying benefits, determining whether therapy falls under the medical or pharmacy benefit, and managing prior authorization requests for infusions, OPAT courses, and specialty drugs. Tracking each request creates visibility into outstanding work and helps the practice connect authorization status with scheduling, billing, and potential unreimbursed drug costs.

Claims support may include charge entry, coding review, claim scrubbing, submission, and rejection clearing for evaluation and management, infusion, and drug claims. Support can be structured as full claims management or overflow assistance, depending on the practice’s workflow. The work is designed to help reduce backlogs while fitting into the practice’s existing systems and infusion operations.

A payment reconciliation review compares received payments with expected reimbursement for drug, administration, and evaluation and management claims. The review can flag short-pays, incorrect fee schedule application, and unit or NDC mismatches. Identified underpayments can then be disputed and tracked to recovery, while recurring findings may inform payer discussions or workflow corrections.

Yes. Denial work can categorize root causes such as drug and administration coding, missing authorization, medical-versus-pharmacy benefit confusion, or under-documented consults. Payer-specific appeals can be prepared using relevant clinical documentation. Findings can also be shared with clinical, coding, and front-office teams so the practice can address recurring causes rather than treating each denial as an isolated event.

The service is designed for infectious disease physicians, independent infectious disease practices, infectious disease group leaders, and medical practice administrators. It can be relevant when launching an infusion suite or OPAT program, adding providers, evaluating revenue streams, reviewing payer performance, or addressing a revenue cycle that no longer matches the practice’s clinical and operational activity.